Literature DB >> 2959413

Alpha-interferon induces enhanced expression of HLA-ABC antigens and beta-2-microglobulin in vivo and in vitro in various subsets of human lymphoid cells.

M H Nissen1, J K Larsen, T Plesner, B K Olesen, P Ernst.   

Abstract

The effect of cloned alpha-interferon (alpha-IFN) on the in vitro and in vivo expression of HLA-ABC antigens and beta-2-microglobulin (beta-2-m) on subpopulations of human lymphoid cells was studied by flow cytometry. Mononuclear cells isolated from patients and cell cultures were labelled with saturating amounts of FITC conjugated monoclonal anti-HLA-ABC or anti-beta-2-m. Phycoerythrin conjugated monoclonal antibodies were simultaneously used for the selection of T lymphocytes. T helper lymphocytes, T suppressor lymphocytes, B lymphocytes and monocytes. In vitro, alpha-IFN induced a significant increase of beta-2-m on all subsets investigated. The increase was more pronounced on B lymphocytes (64%) and monocytes (69%) than on T lymphocytes (39%) (P less than 0.01). Also the pretreatment level of beta-2-m was found to be higher on B lymphocytes (0.64 arbitrary units (a.u.)) and monocytes (0.65 a.u.) than on T lymphocytes (0.24 a.u.) (P less than 0.001). In vivo, the expression of both HLA-ABC antigens and beta-2-m was studied in three patients 24 h after administration of 50 x 10(6) units alpha-IFN/m2 i.m. HLA-ABC antigens were significantly (P less than 0.05) increased on all subsets investigated, except for T suppressor lymphocytes. The increase in beta-2-m only reached significance on T lymphocytes. T helper lymphocytes and monocytes (P less than 0.02). At 48 h after administration of alpha-IFN, expression of HLA-ABC antigens and beta-2-m approached pretreatment levels. Enhanced expression of HLA-ABC antigens and beta-2-m could be reinduced by treatment of alpha-IFN on day 7.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959413      PMCID: PMC1542368     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

Review 1.  Interferon: effects on the immune response and the mechanism of activation of the cellular response.

Authors:  H M Johnson; S Baron
Journal:  CRC Crit Rev Biochem       Date:  1976-11

2.  Enhancement of defective monocyte function during immunotherapy with recombinant interferon.

Authors:  H Nielsen; P Ernst
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  B peripheral lymphocytes express more HLA antigens than T peripheral lymphocytes.

Authors:  M A Pellegrino; M Belvedere; A G Pellegrino; S Ferrone
Journal:  Transplantation       Date:  1978-02       Impact factor: 4.939

4.  Inhibitory effect of interferon preparations and inducers on the multiplication of transplanted allogeneic spleen cells and syngeneic bone marrow cells.

Authors:  J C Cerottini; K T Brunner; P Lindahl; I Gresser
Journal:  Nat New Biol       Date:  1973-04-04

5.  Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes.

Authors:  M Hokland; I Heron; K Berg; P Hokland
Journal:  Cell Immunol       Date:  1982-09-01       Impact factor: 4.868

6.  Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins.

Authors:  G Trinchieri; D Santoli; H Koprowski
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

7.  Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.

Authors:  M H Nissen; T Plesner; J K Larsen; B K Olesen; P Ernst
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

8.  Effect of recombinant alpha interferon on NK and ADCC function in lung cancer patients: results from a phase II trial.

Authors:  P Hokland; M Hokland; B K Olesen; P Ernst
Journal:  J Interferon Res       Date:  1984

9.  Evidence for a change in the expression of beta2-microglobulin-assoicated membrane structures on leukaemic human cells.

Authors:  T Plesner; H Karle; B Rubin; M Thomsen
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

10.  Regulatory effect of interferon on T cells in vitro.

Authors:  I Heron; K Berg; K Cantell
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

View more
  3 in total

1.  In vivo induction of HLA molecules in patients with myeloproliferative syndrome during IFN alpha treatment.

Authors:  C A Müller; J Walz; R Zinser; H J Bühring; B Steinke; H Schmidt
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

2.  Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.

Authors:  Daisuke Katagiri; Masahiro Ishikane; Yusuke Asai; Shinyu Izumi; Jin Takasaki; Hiyori Katsuoka; Isao Kondo; Satoshi Ide; Keiji Nakamura; Takato Nakamoto; Hidetoshi Nomoto; Yutaro Akiyama; Yusuke Miyazato; Tetsuya Suzuki; Noriko Kinoshita; Tatsunori Ogawa; Tomiteru Togano; Manabu Suzuki; Masao Hashimoto; Keita Sakamoto; Yusaku Kusaba; Takashi Katsuno; Takashi Fukaya; Masayuki Hojo; Masaya Sugiyama; Masashi Mizokami; Tatsuya Okamoto; Akio Kimura; Eisei Noiri; Norio Ohmagari; Fumihiko Hinoshita; Haruhito Sugiyama
Journal:  J Clin Apher       Date:  2020-12-15       Impact factor: 2.821

3.  Urinary β2-microglobulin as an early marker of infantile enterovirus and human parechovirus infections.

Authors:  Junji Azuma; Takehisa Yamamoto; Mihoko Sakurai; Ryuko Amou; Chieko Yamada; Kazuhisa Hashimoto; Satomi Kajita; Kyoko Yamamoto; Eri Kijima; Yoshimi Mizoguchi; Keiko Nakata; Tunesuke Shimotsuji; Keiichi Ozono
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.